Skip to content

Clinical trials

Respiratory Syncytial Virus Infections trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Country / region: China Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20201
20213
20223
20237
20247
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting5
Recruiting4
Terminated3
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Ark Biopharmaceutical Co., Ltd.4
Zhuhai Trinomab Pharmaceutical Co., Ltd.3
GlaxoSmithKline2
Guangzhou Patronus Biotech Co., Ltd.2
Hangzhou Sciwind Biosciences Co., Ltd.2
Pfizer2
Vigonvita Life Sciences2
Ab&B Bio-tech Co., Ltd.JS1
Beijing Children's Hospital1
CSPC Ouyi Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections30
Respiratory Tract Infections2
Heart Diseases1
Virus Diseases1

Trials

Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.